Table 3

Comparison of cases with interval cancers and controls with a negative result at a preceding colonoscopy with respect to indication and completeness of colonoscopy

GroupIndication and completeness of colonoscopyCases with interval cancer, N (%)Controls, N (%)p Value
TotalIndication
 Screening30 (39.0)218 (50.9)
 Positive FOBT20 (26.0)55 (12.9)
 Other27 (35.1)155 (36.2)0.009
Complete
 Yes59 (81.9)447 (93.3)
 No13 (18.1)32 (6.7)0.001
MenIndication
 Screening10 (29.4)148 (58.0)
 Positive FOBT12 (35.3)27 (10.6)
 Other12 (35.3)80 (31.4)0.0001
Complete
 Yes29 (90.6)258 (94.5)
 No3 (9.4)15 (5.5)0.37
WomenIndication
 Screening20 (46.5)70 (40.5)
 Positive FOBT8 (18.6)28 (16.2)
 Other15 (34.9)75 (43.4)0.60
Complete
 Yes30 (75.0)189 (91.8)
 No10 (25.0)17 (8.3)0.002
<70 yearsIndication
 Screening18 (40.9)91 (49.2)
 Positive FOBT13 (29.6)24 (13.0)
 Other13 (29.6)70 (37.8)0.03
Complete
 Yes34 (79.1)195 (92.4)
 No9 (20.9)16 (7.6)0.007
≥70 yearsIndication
 Screening12 (36.4)127 (52.3)
 Positive FOBT7 (21.2)31 (12.8)
 Other14 (42.4)85 (35.0)0.18
Complete
 Yes25 (86.2)252 (94.0)
 No4 (13.8)16 (6.0)0.11
  • Numbers of cancers with missing data: sex: 0 (0%), age: 0 (0%), indication: 1 (1.3%), completeness: 6 (7.7%); numbers of controls with missing data: sex: 0 (0%), age: 0 (0%), indication: 87 (16.9%), completeness: 36 (7.0%).

  • FOBT, faecal occult blood test.